Shihpo earned his Ph.D. in Biomedical Engineering from National Yang Ming Chiao Tung University in 2024. During his doctoral studies, he developed a 3D SWIR (short-wave infrared) fluorescence stereo imaging system specifically designed for small animals. This advanced imaging technology allows researchers to capture detailed, three-dimensional views of biological processes in vivo, offering deeper tissue penetration and lower background noise compared to conventional imaging methods. Shihpo joined the Bogyo lab in August 2024 and is currently working on developing 3D SWIR fluorescence imaging using protease-activated probes for cancer research.

Ife earned his B.Sc. in microbiology from the University of Nigeria in 2016. He performed undergraduate research in enzyme biochemistry in the laboratory of Prof. Tochukwu Nwagu where he studied the production of raw starch-degrading amylase from a microbial isolate. Following his first degree, he did post-baccalaureate research in the laboratory of Prof. Anthony Attama at the same institution. His work was focused on the characterization of probiotic yeast isolates. Ife went on to earn his Ph.D. in microbiology and molecular genetics at Michigan State University in 2024 under the mentorship of Prof. Robert Abramovitch. His graduate work was focused on the use of chemical genetic approaches to decipher the mechanisms-of-action of novel nitro-containing compounds that inhibit the growth of Mycobacterium tuberculosis and M. abscessus. In August 2024, Ife joined the Bogyo lab, and his work has revolved around the development of covalent antibiotics, photodynamic therapy for otitis media, and covalent phage display against various targets. 

Jiyun graduated from Sun Yat-sen University in 2019 with her B.Sc. in Chemical Biology, then she joined the laboratory of Prof. Thomas Meek at Texas A&M University and earned her Ph. D in Biochemistry in 2023. Her thesis focuses on elucidating the catalytic mechanism of the Main protease (Mpro) of SARS-CoV-2 and developing inhibitors targeting Mpro and human cathepsin L, two cysteine protease targets in COVID-19 drug development. Jiyun joined the Bogyo lab in October 2023 and is currently working on exploring the therapeutic potential of inhibitors targeting proteases/hydrolases using high-throughput screening methods combined with enzyme kinetics.

Kristyna completed her B.Sc. in Molecular Biology at Charles University in 2012, followed by an M.Sc. in Virology in 2014, where she conducted research on the use of chemically-modified virus-like particles as targeting agents. After completing her M.Sc., she joined the group of Dr. Petr Bartunek at the Institute of Molecular Genetics to study steroid hormone nuclear receptors in cancer using high-throughput phenotypic screening. Kristyna then pursued her Ph.D. in the Konvalinka lab at the Institute of Organic Chemistry and Biochemistry under the mentorship of Prof. Jan Konvalinka. She focused on ligand discovery using various selection methods and the use of polymer chemistry to target immune receptors in autoimmune diseases and cancer immunotherapy. After completing her Ph.D. in 2022, she joined the Bogyo lab to investigate microbial proteases involved in inflammatory bowel disease.

Shiyu earned his B.S. in Chemistry from Wuhan University in 2015. He completed his Ph.D. in 2022 at New York University in the lab of Dr. James Canary. His graduate work focused on developing ratiometric fluorescent probes for peroxynitrite and manganese. Shiyu joined the Bogyo lab in Aug 2022 and is currently working on protease activated probes for preclinical applications.

Emily completed her Ph.D. (2017) and M.D. (2020) through the Emory University Medical Scientist Training Program. She did her Ph.D. work in the lab of Dr. Shonna McBride. Her thesis work primarily focused on genetic mechanisms of the Clostridioides difficile response to host-produced antimicrobials. She subsequently continued her medical training as an Internal Medicine resident at Stanford University (2020-2023). Emily joined the Bogyo lab in July 2023 and is interested in developing in vivo imaging techniques for bacterial infections.

Sijie earned his B.E. in Pharmaceutical Engineering from East China University of Science and Technology in 2014. During his master study in 2014-2016 at University of Southern California, he conducted cancer research under Dr. Pin Wang. In 2016, he joined Dr. Casey Krusemark's lab and Dr. Emily Dykhuizen's lab at Purdue University. His graduate work focused on the development of chemical probes using DNA-encoded libraries to study target functions in cancer. In addition, he also developed cyclic imine-based warheads for selective bioconjudgation of tyrosine and tryptophan. After he earned his Ph.D. in 2022, he joined Bogyo lab as a postdoctoral fellow. He is currently working on the development of covalent cyclic peptidic inhibitors using phage display and mRNA display, as well as developing novel warheads for covalent drug development. 

Jeyun received his Pharm.D. from Pusan National University in 2016 and completed his Ph.D. research in the laboratory of Prof. Hwayoung Yun at the same university in 2021. His thesis studies focused on the first total synthesis of anmindenol A and optimization of 2-anilinopyrimidine-based selective inhibitors against TNBC cells. After working as a senior research scientist at Chong Kun Dang for a year, Jeyun joined the Bogyo lab as a postdoctoral fellow in May of 2022. He is currently working on the development of highly selective inhibitors and probes targeting specific serine hydrolases in pathogenic bacteria and parasites.

Tulsi received her B.Sc. degree in Biotechnology (2009) from Mohanlal Sukhadiya University Udaipur and her M.Sc.degree in Biotechnology (2011) from H. N. B. Garhwal University Srinagar, India. She then joined the Department of Mathematics, Maulana Azad National Institute of Technology Bhopal, India to pursue M. Tech in Bioinformatics (2014). She worked under the guidance of Prof. K.R. Paradasni and Prof. Neeru Adlakha to identify riboswitches in Clostridium difficile and their small-molecule binders using an in silico approach. In January 2015, she started her Ph. D. work in the laboratory of Dr. Ishu Saraogi at the Indian Institute of Science Education and Research, Bhopal. Her thesis focused on studying essential structural features that regulate protein-protein interaction in the bacterial Hsp70 system and the identification of small molecule inhibitors of DnaK. Tulsi joined the Bogyo lab in March 2022. Her current interest is in characterizing the function of serine hydrolases in pathogenic bacteria and developing selective inhibitors using diverse chemical libraries and phage-display approaches.

Nikki graduated from the University of Maryland in 2016 where she earned a B.S. (cum laude) in Chemistry and Biological Sciences. She performed undergraduate research in physical organic chemistry in Prof. Daniel Falvey's lab where she studied photo releasable protecting groups. She went on to earn a Ph.D. in Chemistry from the University of Southern California in 2021 under the mentorship of Prof. Matthew Pratt. Her graduate work centered around the posttranslational modification O-GlcNAcylation. During her time in the Pratt lab, Nikki developed selective inhibitors of O-GlcNAc modifications and investigated its role in fibroblast contraction. Nikki joined the Bogyo lab in October of 2021 and is interested in using covalent inhibitors to investigate the role of key enzymes in mammalian immune responses.

Alyssa graduated with distinction from Duke University in 2020 with a B.A. in Chemistry. While at Duke, she conducted research in the lab of Dr. Emily Derbyshire characterizing the role of host proteins in Toxoplasma gondii infection. Post-graduation, Alyssa worked as a research technician in the lab of Dr. Rustem Ismagilov at the California Institute of Technology where she supported graduate research focused on the development of molecular biology-based diagnostics for the sensitive detection of viral and bacterial pathogens in a range of sample types. In the Fall of 2023, Alyssa began her Ph.D. program in the Department of Microbiology and Immunology at Stanford. She joined the Bogyo lab in Spring of 2024 and is interested in using covalent inhibitors to target fatty acid biosynthesis in Clostridioides difficile growth and sporulation.

Anna is a summer undergraduate research student in the Bogyo Lab. She completed high school at Los Altos High School in 2023. She is currerntly a Junior at Wellesley College majoring in Chemistry and Sociology. She worked in the Bogyo Lab in the Summer of 2024 and plans to return for the Summer of 2025.

Max is summer undergraduate student in the Bogyo Lab. He completed high school at Larchmont Charter High Scool in 2023 and is currently a Junior at Claremont McKenna College in Claremont, CA, majoring in Biochemistry. He will return to the Bogyo Lab in the Summer of 2025.